India's Affordable Weight-Loss Drugs Disrupt Global Pharma Markets

India has emerged as a major hub for producing low-cost weight-loss medications, which are now being exported to patients worldwide. These drugs, often significantly cheaper than their Western counterparts, offer a more accessible option for millions struggling with obesity. The trend reflects broader shifts in the global pharmaceutical market, where Indian manufacturers leverage lower production costs to supply affordable treatments. While the drugs have been praised as game-changers, experts urge caution regarding regulation and long-term effects. The growing demand underscores the urgent need for accessible obesity care across the globe.